Global Cell and Gene Therapy (CGT) Pharmaceuticals Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Cell and Gene Therapy (CGT) Pharmaceuticals market size was valued at US$ 17200 million in 2024 and is forecast to a readjusted size of USD 52400 million by 2031 with a CAGR of 18.5% during review period.
Cell and Gene Therapy (CGT) drugs are a class of innovative treatments that treat diseases by changing the patient's cells or genes. Specifically, CGT drugs usually include: 1. Gene therapy: by introducing, deleting or repairing genes into the patient's cells, the purpose is to correct diseases caused by genetic defects or mutations. For example, gene therapy can deliver normal genes to patients through viral vectors to replace missing or defective genes.
2. Cell therapy: by changing or enhancing the patient's own cells and then re-injecting them into the body for treatment. Common cell therapies include using immune cells (such as CAR-T cells) to treat cancer or using stem cells to repair damaged tissues.
This report is a detailed and comprehensive analysis for global Cell and Gene Therapy (CGT) Pharmaceuticals market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cell and Gene Therapy (CGT) Pharmaceuticals market size and forecasts, in consumption value ($ Million), 2020-2031
Global Cell and Gene Therapy (CGT) Pharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Cell and Gene Therapy (CGT) Pharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Cell and Gene Therapy (CGT) Pharmaceuticals market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy (CGT) Pharmaceuticals
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy (CGT) Pharmaceuticals market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vericel, Castle Creek, Terumo, Nipro, BioCardia, Sanpower Group, Novartis, Gilead Sciences, Inc./Fosun Kite, BMS, JW (Cayman) Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cell and Gene Therapy (CGT) Pharmaceuticals market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy (CGT) Pharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy (CGT) Pharmaceuticals, with revenue, gross margin, and global market share of Cell and Gene Therapy (CGT) Pharmaceuticals from 2020 to 2025.
Chapter 3, the Cell and Gene Therapy (CGT) Pharmaceuticals competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cell and Gene Therapy (CGT) Pharmaceuticals market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy (CGT) Pharmaceuticals.
Chapter 13, to describe Cell and Gene Therapy (CGT) Pharmaceuticals research findings and conclusion.
Cell and Gene Therapy (CGT) drugs are a class of innovative treatments that treat diseases by changing the patient's cells or genes. Specifically, CGT drugs usually include: 1. Gene therapy: by introducing, deleting or repairing genes into the patient's cells, the purpose is to correct diseases caused by genetic defects or mutations. For example, gene therapy can deliver normal genes to patients through viral vectors to replace missing or defective genes.
2. Cell therapy: by changing or enhancing the patient's own cells and then re-injecting them into the body for treatment. Common cell therapies include using immune cells (such as CAR-T cells) to treat cancer or using stem cells to repair damaged tissues.
This report is a detailed and comprehensive analysis for global Cell and Gene Therapy (CGT) Pharmaceuticals market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cell and Gene Therapy (CGT) Pharmaceuticals market size and forecasts, in consumption value ($ Million), 2020-2031
Global Cell and Gene Therapy (CGT) Pharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Cell and Gene Therapy (CGT) Pharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Cell and Gene Therapy (CGT) Pharmaceuticals market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell and Gene Therapy (CGT) Pharmaceuticals
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell and Gene Therapy (CGT) Pharmaceuticals market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vericel, Castle Creek, Terumo, Nipro, BioCardia, Sanpower Group, Novartis, Gilead Sciences, Inc./Fosun Kite, BMS, JW (Cayman) Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cell and Gene Therapy (CGT) Pharmaceuticals market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Cell Therapy Drugs
- Gene Therapy Drugs
- Hospital
- Clinic
- Other
- Vericel
- Castle Creek
- Terumo
- Nipro
- BioCardia
- Sanpower Group
- Novartis
- Gilead Sciences, Inc./Fosun Kite
- BMS
- JW (Cayman) Therapeutics
- Legend Biotech Corp./Johnson & Johnson
- Innovent Biologics, Inc./IASO Biotherapeutics
- Juventas/CASI
- CARsgen Therapeutics Holdings
- Huadong Medicine
- inno.N
- lovance
- Mesoblast
- Takeda
- Pierre fabre
- Aurion Biotech
- Gamida Cell
- CellTrans
- SiBiono Gene Technology
- Ferring
- Kyowa Kirin
- uniQure
- Roche
- PTC Therapeutics
- BioMarin
- CSL
- Sarepta
- AnGes
- bluebird bio
- Krystal Biotech
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell and Gene Therapy (CGT) Pharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy (CGT) Pharmaceuticals, with revenue, gross margin, and global market share of Cell and Gene Therapy (CGT) Pharmaceuticals from 2020 to 2025.
Chapter 3, the Cell and Gene Therapy (CGT) Pharmaceuticals competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cell and Gene Therapy (CGT) Pharmaceuticals market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy (CGT) Pharmaceuticals.
Chapter 13, to describe Cell and Gene Therapy (CGT) Pharmaceuticals research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy (CGT) Pharmaceuticals by Type
1.3.1 Overview: Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type in 2024
1.3.3 Cell Therapy Drugs
1.3.4 Gene Therapy Drugs
1.4 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market by Application
1.4.1 Overview: Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size & Forecast
1.6 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region, (2020-2031)
1.6.3 North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Prospect (2020-2031)
1.6.4 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Prospect (2020-2031)
1.6.6 South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Vericel
2.1.1 Vericel Details
2.1.2 Vericel Major Business
2.1.3 Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.1.4 Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Vericel Recent Developments and Future Plans
2.2 Castle Creek
2.2.1 Castle Creek Details
2.2.2 Castle Creek Major Business
2.2.3 Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.2.4 Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Castle Creek Recent Developments and Future Plans
2.3 Terumo
2.3.1 Terumo Details
2.3.2 Terumo Major Business
2.3.3 Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.3.4 Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Terumo Recent Developments and Future Plans
2.4 Nipro
2.4.1 Nipro Details
2.4.2 Nipro Major Business
2.4.3 Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.4.4 Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Nipro Recent Developments and Future Plans
2.5 BioCardia
2.5.1 BioCardia Details
2.5.2 BioCardia Major Business
2.5.3 BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.5.4 BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 BioCardia Recent Developments and Future Plans
2.6 Sanpower Group
2.6.1 Sanpower Group Details
2.6.2 Sanpower Group Major Business
2.6.3 Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.6.4 Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Sanpower Group Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.7.4 Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Gilead Sciences, Inc./Fosun Kite
2.8.1 Gilead Sciences, Inc./Fosun Kite Details
2.8.2 Gilead Sciences, Inc./Fosun Kite Major Business
2.8.3 Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.8.4 Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Gilead Sciences, Inc./Fosun Kite Recent Developments and Future Plans
2.9 BMS
2.9.1 BMS Details
2.9.2 BMS Major Business
2.9.3 BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.9.4 BMS Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 BMS Recent Developments and Future Plans
2.10 JW (Cayman) Therapeutics
2.10.1 JW (Cayman) Therapeutics Details
2.10.2 JW (Cayman) Therapeutics Major Business
2.10.3 JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.10.4 JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 JW (Cayman) Therapeutics Recent Developments and Future Plans
2.11 Legend Biotech Corp./Johnson & Johnson
2.11.1 Legend Biotech Corp./Johnson & Johnson Details
2.11.2 Legend Biotech Corp./Johnson & Johnson Major Business
2.11.3 Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.11.4 Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Legend Biotech Corp./Johnson & Johnson Recent Developments and Future Plans
2.12 Innovent Biologics, Inc./IASO Biotherapeutics
2.12.1 Innovent Biologics, Inc./IASO Biotherapeutics Details
2.12.2 Innovent Biologics, Inc./IASO Biotherapeutics Major Business
2.12.3 Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.12.4 Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Innovent Biologics, Inc./IASO Biotherapeutics Recent Developments and Future Plans
2.13 Juventas/CASI
2.13.1 Juventas/CASI Details
2.13.2 Juventas/CASI Major Business
2.13.3 Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.13.4 Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Juventas/CASI Recent Developments and Future Plans
2.14 CARsgen Therapeutics Holdings
2.14.1 CARsgen Therapeutics Holdings Details
2.14.2 CARsgen Therapeutics Holdings Major Business
2.14.3 CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.14.4 CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 CARsgen Therapeutics Holdings Recent Developments and Future Plans
2.15 Huadong Medicine
2.15.1 Huadong Medicine Details
2.15.2 Huadong Medicine Major Business
2.15.3 Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.15.4 Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Huadong Medicine Recent Developments and Future Plans
2.16 inno.N
2.16.1 inno.N Details
2.16.2 inno.N Major Business
2.16.3 inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.16.4 inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 inno.N Recent Developments and Future Plans
2.17 lovance
2.17.1 lovance Details
2.17.2 lovance Major Business
2.17.3 lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.17.4 lovance Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 lovance Recent Developments and Future Plans
2.18 Mesoblast
2.18.1 Mesoblast Details
2.18.2 Mesoblast Major Business
2.18.3 Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.18.4 Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Mesoblast Recent Developments and Future Plans
2.19 Takeda
2.19.1 Takeda Details
2.19.2 Takeda Major Business
2.19.3 Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.19.4 Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Takeda Recent Developments and Future Plans
2.20 Pierre fabre
2.20.1 Pierre fabre Details
2.20.2 Pierre fabre Major Business
2.20.3 Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.20.4 Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Pierre fabre Recent Developments and Future Plans
2.21 Aurion Biotech
2.21.1 Aurion Biotech Details
2.21.2 Aurion Biotech Major Business
2.21.3 Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.21.4 Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Aurion Biotech Recent Developments and Future Plans
2.22 Gamida Cell
2.22.1 Gamida Cell Details
2.22.2 Gamida Cell Major Business
2.22.3 Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.22.4 Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Gamida Cell Recent Developments and Future Plans
2.23 CellTrans
2.23.1 CellTrans Details
2.23.2 CellTrans Major Business
2.23.3 CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.23.4 CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 CellTrans Recent Developments and Future Plans
2.24 SiBiono Gene Technology
2.24.1 SiBiono Gene Technology Details
2.24.2 SiBiono Gene Technology Major Business
2.24.3 SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.24.4 SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 SiBiono Gene Technology Recent Developments and Future Plans
2.25 Ferring
2.25.1 Ferring Details
2.25.2 Ferring Major Business
2.25.3 Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.25.4 Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 Ferring Recent Developments and Future Plans
2.26 Kyowa Kirin
2.26.1 Kyowa Kirin Details
2.26.2 Kyowa Kirin Major Business
2.26.3 Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.26.4 Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.26.5 Kyowa Kirin Recent Developments and Future Plans
2.27 uniQure
2.27.1 uniQure Details
2.27.2 uniQure Major Business
2.27.3 uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.27.4 uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.27.5 uniQure Recent Developments and Future Plans
2.28 Roche
2.28.1 Roche Details
2.28.2 Roche Major Business
2.28.3 Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.28.4 Roche Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.28.5 Roche Recent Developments and Future Plans
2.29 PTC Therapeutics
2.29.1 PTC Therapeutics Details
2.29.2 PTC Therapeutics Major Business
2.29.3 PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.29.4 PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.29.5 PTC Therapeutics Recent Developments and Future Plans
2.30 BioMarin
2.30.1 BioMarin Details
2.30.2 BioMarin Major Business
2.30.3 BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.30.4 BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.30.5 BioMarin Recent Developments and Future Plans
2.31 CSL
2.31.1 CSL Details
2.31.2 CSL Major Business
2.31.3 CSL Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.31.4 CSL Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.31.5 CSL Recent Developments and Future Plans
2.32 Sarepta
2.32.1 Sarepta Details
2.32.2 Sarepta Major Business
2.32.3 Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.32.4 Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.32.5 Sarepta Recent Developments and Future Plans
2.33 AnGes
2.33.1 AnGes Details
2.33.2 AnGes Major Business
2.33.3 AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.33.4 AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.33.5 AnGes Recent Developments and Future Plans
2.34 bluebird bio
2.34.1 bluebird bio Details
2.34.2 bluebird bio Major Business
2.34.3 bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.34.4 bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.34.5 bluebird bio Recent Developments and Future Plans
2.35 Krystal Biotech
2.35.1 Krystal Biotech Details
2.35.2 Krystal Biotech Major Business
2.35.3 Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.35.4 Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.35.5 Krystal Biotech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Cell and Gene Therapy (CGT) Pharmaceuticals by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy (CGT) Pharmaceuticals Players Market Share in 2024
3.2.3 Top 6 Cell and Gene Therapy (CGT) Pharmaceuticals Players Market Share in 2024
3.3 Cell and Gene Therapy (CGT) Pharmaceuticals Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy (CGT) Pharmaceuticals Market: Region Footprint
3.3.2 Cell and Gene Therapy (CGT) Pharmaceuticals Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy (CGT) Pharmaceuticals Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value and Market Share by Type (2020-2025)
4.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application (2020-2025)
5.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2031)
6.2 North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2020-2031)
6.3 North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
6.3.1 North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2031)
6.3.2 United States Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
6.3.3 Canada Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
6.3.4 Mexico Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2031)
7.2 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2031)
7.3 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
7.3.1 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2031)
7.3.2 Germany Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
7.3.3 France Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
7.3.5 Russia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
7.3.6 Italy Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Region (2020-2031)
8.3.2 China Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
8.3.3 Japan Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
8.3.4 South Korea Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
8.3.5 India Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
8.3.7 Australia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2031)
9.2 South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2031)
9.3 South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
9.3.1 South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2031)
9.3.2 Brazil Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
9.3.3 Argentina Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2031)
10.3.2 Turkey Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
10.3.4 UAE Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Cell and Gene Therapy (CGT) Pharmaceuticals Market Drivers
11.2 Cell and Gene Therapy (CGT) Pharmaceuticals Market Restraints
11.3 Cell and Gene Therapy (CGT) Pharmaceuticals Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Cell and Gene Therapy (CGT) Pharmaceuticals Industry Chain
12.2 Cell and Gene Therapy (CGT) Pharmaceuticals Upstream Analysis
12.3 Cell and Gene Therapy (CGT) Pharmaceuticals Midstream Analysis
12.4 Cell and Gene Therapy (CGT) Pharmaceuticals Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy (CGT) Pharmaceuticals by Type
1.3.1 Overview: Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type in 2024
1.3.3 Cell Therapy Drugs
1.3.4 Gene Therapy Drugs
1.4 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market by Application
1.4.1 Overview: Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size & Forecast
1.6 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region, (2020-2031)
1.6.3 North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Prospect (2020-2031)
1.6.4 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Prospect (2020-2031)
1.6.6 South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Vericel
2.1.1 Vericel Details
2.1.2 Vericel Major Business
2.1.3 Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.1.4 Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Vericel Recent Developments and Future Plans
2.2 Castle Creek
2.2.1 Castle Creek Details
2.2.2 Castle Creek Major Business
2.2.3 Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.2.4 Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Castle Creek Recent Developments and Future Plans
2.3 Terumo
2.3.1 Terumo Details
2.3.2 Terumo Major Business
2.3.3 Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.3.4 Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Terumo Recent Developments and Future Plans
2.4 Nipro
2.4.1 Nipro Details
2.4.2 Nipro Major Business
2.4.3 Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.4.4 Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Nipro Recent Developments and Future Plans
2.5 BioCardia
2.5.1 BioCardia Details
2.5.2 BioCardia Major Business
2.5.3 BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.5.4 BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 BioCardia Recent Developments and Future Plans
2.6 Sanpower Group
2.6.1 Sanpower Group Details
2.6.2 Sanpower Group Major Business
2.6.3 Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.6.4 Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Sanpower Group Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.7.4 Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Gilead Sciences, Inc./Fosun Kite
2.8.1 Gilead Sciences, Inc./Fosun Kite Details
2.8.2 Gilead Sciences, Inc./Fosun Kite Major Business
2.8.3 Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.8.4 Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Gilead Sciences, Inc./Fosun Kite Recent Developments and Future Plans
2.9 BMS
2.9.1 BMS Details
2.9.2 BMS Major Business
2.9.3 BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.9.4 BMS Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 BMS Recent Developments and Future Plans
2.10 JW (Cayman) Therapeutics
2.10.1 JW (Cayman) Therapeutics Details
2.10.2 JW (Cayman) Therapeutics Major Business
2.10.3 JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.10.4 JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 JW (Cayman) Therapeutics Recent Developments and Future Plans
2.11 Legend Biotech Corp./Johnson & Johnson
2.11.1 Legend Biotech Corp./Johnson & Johnson Details
2.11.2 Legend Biotech Corp./Johnson & Johnson Major Business
2.11.3 Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.11.4 Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Legend Biotech Corp./Johnson & Johnson Recent Developments and Future Plans
2.12 Innovent Biologics, Inc./IASO Biotherapeutics
2.12.1 Innovent Biologics, Inc./IASO Biotherapeutics Details
2.12.2 Innovent Biologics, Inc./IASO Biotherapeutics Major Business
2.12.3 Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.12.4 Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Innovent Biologics, Inc./IASO Biotherapeutics Recent Developments and Future Plans
2.13 Juventas/CASI
2.13.1 Juventas/CASI Details
2.13.2 Juventas/CASI Major Business
2.13.3 Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.13.4 Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Juventas/CASI Recent Developments and Future Plans
2.14 CARsgen Therapeutics Holdings
2.14.1 CARsgen Therapeutics Holdings Details
2.14.2 CARsgen Therapeutics Holdings Major Business
2.14.3 CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.14.4 CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 CARsgen Therapeutics Holdings Recent Developments and Future Plans
2.15 Huadong Medicine
2.15.1 Huadong Medicine Details
2.15.2 Huadong Medicine Major Business
2.15.3 Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.15.4 Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Huadong Medicine Recent Developments and Future Plans
2.16 inno.N
2.16.1 inno.N Details
2.16.2 inno.N Major Business
2.16.3 inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.16.4 inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 inno.N Recent Developments and Future Plans
2.17 lovance
2.17.1 lovance Details
2.17.2 lovance Major Business
2.17.3 lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.17.4 lovance Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 lovance Recent Developments and Future Plans
2.18 Mesoblast
2.18.1 Mesoblast Details
2.18.2 Mesoblast Major Business
2.18.3 Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.18.4 Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Mesoblast Recent Developments and Future Plans
2.19 Takeda
2.19.1 Takeda Details
2.19.2 Takeda Major Business
2.19.3 Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.19.4 Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Takeda Recent Developments and Future Plans
2.20 Pierre fabre
2.20.1 Pierre fabre Details
2.20.2 Pierre fabre Major Business
2.20.3 Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.20.4 Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Pierre fabre Recent Developments and Future Plans
2.21 Aurion Biotech
2.21.1 Aurion Biotech Details
2.21.2 Aurion Biotech Major Business
2.21.3 Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.21.4 Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Aurion Biotech Recent Developments and Future Plans
2.22 Gamida Cell
2.22.1 Gamida Cell Details
2.22.2 Gamida Cell Major Business
2.22.3 Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.22.4 Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Gamida Cell Recent Developments and Future Plans
2.23 CellTrans
2.23.1 CellTrans Details
2.23.2 CellTrans Major Business
2.23.3 CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.23.4 CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 CellTrans Recent Developments and Future Plans
2.24 SiBiono Gene Technology
2.24.1 SiBiono Gene Technology Details
2.24.2 SiBiono Gene Technology Major Business
2.24.3 SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.24.4 SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 SiBiono Gene Technology Recent Developments and Future Plans
2.25 Ferring
2.25.1 Ferring Details
2.25.2 Ferring Major Business
2.25.3 Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.25.4 Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 Ferring Recent Developments and Future Plans
2.26 Kyowa Kirin
2.26.1 Kyowa Kirin Details
2.26.2 Kyowa Kirin Major Business
2.26.3 Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.26.4 Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.26.5 Kyowa Kirin Recent Developments and Future Plans
2.27 uniQure
2.27.1 uniQure Details
2.27.2 uniQure Major Business
2.27.3 uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.27.4 uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.27.5 uniQure Recent Developments and Future Plans
2.28 Roche
2.28.1 Roche Details
2.28.2 Roche Major Business
2.28.3 Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.28.4 Roche Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.28.5 Roche Recent Developments and Future Plans
2.29 PTC Therapeutics
2.29.1 PTC Therapeutics Details
2.29.2 PTC Therapeutics Major Business
2.29.3 PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.29.4 PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.29.5 PTC Therapeutics Recent Developments and Future Plans
2.30 BioMarin
2.30.1 BioMarin Details
2.30.2 BioMarin Major Business
2.30.3 BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.30.4 BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.30.5 BioMarin Recent Developments and Future Plans
2.31 CSL
2.31.1 CSL Details
2.31.2 CSL Major Business
2.31.3 CSL Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.31.4 CSL Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.31.5 CSL Recent Developments and Future Plans
2.32 Sarepta
2.32.1 Sarepta Details
2.32.2 Sarepta Major Business
2.32.3 Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.32.4 Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.32.5 Sarepta Recent Developments and Future Plans
2.33 AnGes
2.33.1 AnGes Details
2.33.2 AnGes Major Business
2.33.3 AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.33.4 AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.33.5 AnGes Recent Developments and Future Plans
2.34 bluebird bio
2.34.1 bluebird bio Details
2.34.2 bluebird bio Major Business
2.34.3 bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.34.4 bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.34.5 bluebird bio Recent Developments and Future Plans
2.35 Krystal Biotech
2.35.1 Krystal Biotech Details
2.35.2 Krystal Biotech Major Business
2.35.3 Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
2.35.4 Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Revenue, Gross Margin and Market Share (2020-2025)
2.35.5 Krystal Biotech Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Cell and Gene Therapy (CGT) Pharmaceuticals by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy (CGT) Pharmaceuticals Players Market Share in 2024
3.2.3 Top 6 Cell and Gene Therapy (CGT) Pharmaceuticals Players Market Share in 2024
3.3 Cell and Gene Therapy (CGT) Pharmaceuticals Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy (CGT) Pharmaceuticals Market: Region Footprint
3.3.2 Cell and Gene Therapy (CGT) Pharmaceuticals Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy (CGT) Pharmaceuticals Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value and Market Share by Type (2020-2025)
4.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application (2020-2025)
5.2 Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2031)
6.2 North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Application (2020-2031)
6.3 North America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
6.3.1 North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2031)
6.3.2 United States Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
6.3.3 Canada Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
6.3.4 Mexico Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2031)
7.2 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2031)
7.3 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
7.3.1 Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2031)
7.3.2 Germany Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
7.3.3 France Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
7.3.5 Russia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
7.3.6 Italy Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Region (2020-2031)
8.3.2 China Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
8.3.3 Japan Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
8.3.4 South Korea Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
8.3.5 India Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
8.3.7 Australia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2031)
9.2 South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2031)
9.3 South America Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
9.3.1 South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2031)
9.3.2 Brazil Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
9.3.3 Argentina Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2031)
10.3.2 Turkey Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
10.3.4 UAE Cell and Gene Therapy (CGT) Pharmaceuticals Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Cell and Gene Therapy (CGT) Pharmaceuticals Market Drivers
11.2 Cell and Gene Therapy (CGT) Pharmaceuticals Market Restraints
11.3 Cell and Gene Therapy (CGT) Pharmaceuticals Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Cell and Gene Therapy (CGT) Pharmaceuticals Industry Chain
12.2 Cell and Gene Therapy (CGT) Pharmaceuticals Upstream Analysis
12.3 Cell and Gene Therapy (CGT) Pharmaceuticals Midstream Analysis
12.4 Cell and Gene Therapy (CGT) Pharmaceuticals Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Vericel Company Information, Head Office, and Major Competitors
Table 6. Vericel Major Business
Table 7. Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 8. Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Vericel Recent Developments and Future Plans
Table 10. Castle Creek Company Information, Head Office, and Major Competitors
Table 11. Castle Creek Major Business
Table 12. Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 13. Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Castle Creek Recent Developments and Future Plans
Table 15. Terumo Company Information, Head Office, and Major Competitors
Table 16. Terumo Major Business
Table 17. Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 18. Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Nipro Company Information, Head Office, and Major Competitors
Table 20. Nipro Major Business
Table 21. Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 22. Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Nipro Recent Developments and Future Plans
Table 24. BioCardia Company Information, Head Office, and Major Competitors
Table 25. BioCardia Major Business
Table 26. BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 27. BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. BioCardia Recent Developments and Future Plans
Table 29. Sanpower Group Company Information, Head Office, and Major Competitors
Table 30. Sanpower Group Major Business
Table 31. Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 32. Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Sanpower Group Recent Developments and Future Plans
Table 34. Novartis Company Information, Head Office, and Major Competitors
Table 35. Novartis Major Business
Table 36. Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 37. Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Novartis Recent Developments and Future Plans
Table 39. Gilead Sciences, Inc./Fosun Kite Company Information, Head Office, and Major Competitors
Table 40. Gilead Sciences, Inc./Fosun Kite Major Business
Table 41. Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 42. Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Gilead Sciences, Inc./Fosun Kite Recent Developments and Future Plans
Table 44. BMS Company Information, Head Office, and Major Competitors
Table 45. BMS Major Business
Table 46. BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 47. BMS Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. BMS Recent Developments and Future Plans
Table 49. JW (Cayman) Therapeutics Company Information, Head Office, and Major Competitors
Table 50. JW (Cayman) Therapeutics Major Business
Table 51. JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 52. JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. JW (Cayman) Therapeutics Recent Developments and Future Plans
Table 54. Legend Biotech Corp./Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 55. Legend Biotech Corp./Johnson & Johnson Major Business
Table 56. Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 57. Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Legend Biotech Corp./Johnson & Johnson Recent Developments and Future Plans
Table 59. Innovent Biologics, Inc./IASO Biotherapeutics Company Information, Head Office, and Major Competitors
Table 60. Innovent Biologics, Inc./IASO Biotherapeutics Major Business
Table 61. Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 62. Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Innovent Biologics, Inc./IASO Biotherapeutics Recent Developments and Future Plans
Table 64. Juventas/CASI Company Information, Head Office, and Major Competitors
Table 65. Juventas/CASI Major Business
Table 66. Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 67. Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Juventas/CASI Recent Developments and Future Plans
Table 69. CARsgen Therapeutics Holdings Company Information, Head Office, and Major Competitors
Table 70. CARsgen Therapeutics Holdings Major Business
Table 71. CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 72. CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. CARsgen Therapeutics Holdings Recent Developments and Future Plans
Table 74. Huadong Medicine Company Information, Head Office, and Major Competitors
Table 75. Huadong Medicine Major Business
Table 76. Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 77. Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Huadong Medicine Recent Developments and Future Plans
Table 79. inno.N Company Information, Head Office, and Major Competitors
Table 80. inno.N Major Business
Table 81. inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 82. inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. inno.N Recent Developments and Future Plans
Table 84. lovance Company Information, Head Office, and Major Competitors
Table 85. lovance Major Business
Table 86. lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 87. lovance Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. lovance Recent Developments and Future Plans
Table 89. Mesoblast Company Information, Head Office, and Major Competitors
Table 90. Mesoblast Major Business
Table 91. Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 92. Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. Mesoblast Recent Developments and Future Plans
Table 94. Takeda Company Information, Head Office, and Major Competitors
Table 95. Takeda Major Business
Table 96. Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 97. Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 98. Takeda Recent Developments and Future Plans
Table 99. Pierre fabre Company Information, Head Office, and Major Competitors
Table 100. Pierre fabre Major Business
Table 101. Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 102. Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 103. Pierre fabre Recent Developments and Future Plans
Table 104. Aurion Biotech Company Information, Head Office, and Major Competitors
Table 105. Aurion Biotech Major Business
Table 106. Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 107. Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 108. Aurion Biotech Recent Developments and Future Plans
Table 109. Gamida Cell Company Information, Head Office, and Major Competitors
Table 110. Gamida Cell Major Business
Table 111. Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 112. Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 113. Gamida Cell Recent Developments and Future Plans
Table 114. CellTrans Company Information, Head Office, and Major Competitors
Table 115. CellTrans Major Business
Table 116. CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 117. CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 118. CellTrans Recent Developments and Future Plans
Table 119. SiBiono Gene Technology Company Information, Head Office, and Major Competitors
Table 120. SiBiono Gene Technology Major Business
Table 121. SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 122. SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 123. SiBiono Gene Technology Recent Developments and Future Plans
Table 124. Ferring Company Information, Head Office, and Major Competitors
Table 125. Ferring Major Business
Table 126. Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 127. Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 128. Ferring Recent Developments and Future Plans
Table 129. Kyowa Kirin Company Information, Head Office, and Major Competitors
Table 130. Kyowa Kirin Major Business
Table 131. Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 132. Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 133. Kyowa Kirin Recent Developments and Future Plans
Table 134. uniQure Company Information, Head Office, and Major Competitors
Table 135. uniQure Major Business
Table 136. uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 137. uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 138. uniQure Recent Developments and Future Plans
Table 139. Roche Company Information, Head Office, and Major Competitors
Table 140. Roche Major Business
Table 141. Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 142. Roche Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 143. Roche Recent Developments and Future Plans
Table 144. PTC Therapeutics Company Information, Head Office, and Major Competitors
Table 145. PTC Therapeutics Major Business
Table 146. PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 147. PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 148. PTC Therapeutics Recent Developments and Future Plans
Table 149. BioMarin Company Information, Head Office, and Major Competitors
Table 150. BioMarin Major Business
Table 151. BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 152. BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 153. BioMarin Recent Developments and Future Plans
Table 154. CSL Company Information, Head Office, and Major Competitors
Table 155. CSL Major Business
Table 156. CSL Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 157. CSL Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 158. CSL Recent Developments and Future Plans
Table 159. Sarepta Company Information, Head Office, and Major Competitors
Table 160. Sarepta Major Business
Table 161. Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 162. Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 163. Sarepta Recent Developments and Future Plans
Table 164. AnGes Company Information, Head Office, and Major Competitors
Table 165. AnGes Major Business
Table 166. AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 167. AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 168. AnGes Recent Developments and Future Plans
Table 169. bluebird bio Company Information, Head Office, and Major Competitors
Table 170. bluebird bio Major Business
Table 171. bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 172. bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 173. bluebird bio Recent Developments and Future Plans
Table 174. Krystal Biotech Company Information, Head Office, and Major Competitors
Table 175. Krystal Biotech Major Business
Table 176. Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 177. Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 178. Krystal Biotech Recent Developments and Future Plans
Table 179. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million) by Players (2020-2025)
Table 180. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Share by Players (2020-2025)
Table 181. Breakdown of Cell and Gene Therapy (CGT) Pharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3)
Table 182. Market Position of Players in Cell and Gene Therapy (CGT) Pharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 183. Head Office of Key Cell and Gene Therapy (CGT) Pharmaceuticals Players
Table 184. Cell and Gene Therapy (CGT) Pharmaceuticals Market: Company Product Type Footprint
Table 185. Cell and Gene Therapy (CGT) Pharmaceuticals Market: Company Product Application Footprint
Table 186. Cell and Gene Therapy (CGT) Pharmaceuticals New Market Entrants and Barriers to Market Entry
Table 187. Cell and Gene Therapy (CGT) Pharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 188. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (USD Million) by Type (2020-2025)
Table 189. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Share by Type (2020-2025)
Table 190. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Forecast by Type (2026-2031)
Table 191. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2025)
Table 192. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Forecast by Application (2026-2031)
Table 193. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2025) & (USD Million)
Table 194. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2026-2031) & (USD Million)
Table 195. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2025) & (USD Million)
Table 196. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2026-2031) & (USD Million)
Table 197. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2025) & (USD Million)
Table 198. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2026-2031) & (USD Million)
Table 199. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2025) & (USD Million)
Table 200. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2026-2031) & (USD Million)
Table 201. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2025) & (USD Million)
Table 202. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2026-2031) & (USD Million)
Table 203. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2025) & (USD Million)
Table 204. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2026-2031) & (USD Million)
Table 205. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2025) & (USD Million)
Table 206. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2026-2031) & (USD Million)
Table 207. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2025) & (USD Million)
Table 208. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2026-2031) & (USD Million)
Table 209. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Region (2020-2025) & (USD Million)
Table 210. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Region (2026-2031) & (USD Million)
Table 211. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2025) & (USD Million)
Table 212. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2026-2031) & (USD Million)
Table 213. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2025) & (USD Million)
Table 214. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2026-2031) & (USD Million)
Table 215. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2025) & (USD Million)
Table 216. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2026-2031) & (USD Million)
Table 217. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2025) & (USD Million)
Table 218. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2026-2031) & (USD Million)
Table 219. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2025) & (USD Million)
Table 220. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2026-2031) & (USD Million)
Table 221. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2025) & (USD Million)
Table 222. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2026-2031) & (USD Million)
Table 223. Global Key Players of Cell and Gene Therapy (CGT) Pharmaceuticals Upstream (Raw Materials)
Table 224. Global Cell and Gene Therapy (CGT) Pharmaceuticals Typical Customers
Table 1. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Vericel Company Information, Head Office, and Major Competitors
Table 6. Vericel Major Business
Table 7. Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 8. Vericel Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Vericel Recent Developments and Future Plans
Table 10. Castle Creek Company Information, Head Office, and Major Competitors
Table 11. Castle Creek Major Business
Table 12. Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 13. Castle Creek Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Castle Creek Recent Developments and Future Plans
Table 15. Terumo Company Information, Head Office, and Major Competitors
Table 16. Terumo Major Business
Table 17. Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 18. Terumo Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Nipro Company Information, Head Office, and Major Competitors
Table 20. Nipro Major Business
Table 21. Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 22. Nipro Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Nipro Recent Developments and Future Plans
Table 24. BioCardia Company Information, Head Office, and Major Competitors
Table 25. BioCardia Major Business
Table 26. BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 27. BioCardia Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. BioCardia Recent Developments and Future Plans
Table 29. Sanpower Group Company Information, Head Office, and Major Competitors
Table 30. Sanpower Group Major Business
Table 31. Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 32. Sanpower Group Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Sanpower Group Recent Developments and Future Plans
Table 34. Novartis Company Information, Head Office, and Major Competitors
Table 35. Novartis Major Business
Table 36. Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 37. Novartis Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Novartis Recent Developments and Future Plans
Table 39. Gilead Sciences, Inc./Fosun Kite Company Information, Head Office, and Major Competitors
Table 40. Gilead Sciences, Inc./Fosun Kite Major Business
Table 41. Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 42. Gilead Sciences, Inc./Fosun Kite Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Gilead Sciences, Inc./Fosun Kite Recent Developments and Future Plans
Table 44. BMS Company Information, Head Office, and Major Competitors
Table 45. BMS Major Business
Table 46. BMS Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 47. BMS Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. BMS Recent Developments and Future Plans
Table 49. JW (Cayman) Therapeutics Company Information, Head Office, and Major Competitors
Table 50. JW (Cayman) Therapeutics Major Business
Table 51. JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 52. JW (Cayman) Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. JW (Cayman) Therapeutics Recent Developments and Future Plans
Table 54. Legend Biotech Corp./Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 55. Legend Biotech Corp./Johnson & Johnson Major Business
Table 56. Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 57. Legend Biotech Corp./Johnson & Johnson Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Legend Biotech Corp./Johnson & Johnson Recent Developments and Future Plans
Table 59. Innovent Biologics, Inc./IASO Biotherapeutics Company Information, Head Office, and Major Competitors
Table 60. Innovent Biologics, Inc./IASO Biotherapeutics Major Business
Table 61. Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 62. Innovent Biologics, Inc./IASO Biotherapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Innovent Biologics, Inc./IASO Biotherapeutics Recent Developments and Future Plans
Table 64. Juventas/CASI Company Information, Head Office, and Major Competitors
Table 65. Juventas/CASI Major Business
Table 66. Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 67. Juventas/CASI Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Juventas/CASI Recent Developments and Future Plans
Table 69. CARsgen Therapeutics Holdings Company Information, Head Office, and Major Competitors
Table 70. CARsgen Therapeutics Holdings Major Business
Table 71. CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 72. CARsgen Therapeutics Holdings Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. CARsgen Therapeutics Holdings Recent Developments and Future Plans
Table 74. Huadong Medicine Company Information, Head Office, and Major Competitors
Table 75. Huadong Medicine Major Business
Table 76. Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 77. Huadong Medicine Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Huadong Medicine Recent Developments and Future Plans
Table 79. inno.N Company Information, Head Office, and Major Competitors
Table 80. inno.N Major Business
Table 81. inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 82. inno.N Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. inno.N Recent Developments and Future Plans
Table 84. lovance Company Information, Head Office, and Major Competitors
Table 85. lovance Major Business
Table 86. lovance Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 87. lovance Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. lovance Recent Developments and Future Plans
Table 89. Mesoblast Company Information, Head Office, and Major Competitors
Table 90. Mesoblast Major Business
Table 91. Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 92. Mesoblast Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. Mesoblast Recent Developments and Future Plans
Table 94. Takeda Company Information, Head Office, and Major Competitors
Table 95. Takeda Major Business
Table 96. Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 97. Takeda Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 98. Takeda Recent Developments and Future Plans
Table 99. Pierre fabre Company Information, Head Office, and Major Competitors
Table 100. Pierre fabre Major Business
Table 101. Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 102. Pierre fabre Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 103. Pierre fabre Recent Developments and Future Plans
Table 104. Aurion Biotech Company Information, Head Office, and Major Competitors
Table 105. Aurion Biotech Major Business
Table 106. Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 107. Aurion Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 108. Aurion Biotech Recent Developments and Future Plans
Table 109. Gamida Cell Company Information, Head Office, and Major Competitors
Table 110. Gamida Cell Major Business
Table 111. Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 112. Gamida Cell Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 113. Gamida Cell Recent Developments and Future Plans
Table 114. CellTrans Company Information, Head Office, and Major Competitors
Table 115. CellTrans Major Business
Table 116. CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 117. CellTrans Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 118. CellTrans Recent Developments and Future Plans
Table 119. SiBiono Gene Technology Company Information, Head Office, and Major Competitors
Table 120. SiBiono Gene Technology Major Business
Table 121. SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 122. SiBiono Gene Technology Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 123. SiBiono Gene Technology Recent Developments and Future Plans
Table 124. Ferring Company Information, Head Office, and Major Competitors
Table 125. Ferring Major Business
Table 126. Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 127. Ferring Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 128. Ferring Recent Developments and Future Plans
Table 129. Kyowa Kirin Company Information, Head Office, and Major Competitors
Table 130. Kyowa Kirin Major Business
Table 131. Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 132. Kyowa Kirin Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 133. Kyowa Kirin Recent Developments and Future Plans
Table 134. uniQure Company Information, Head Office, and Major Competitors
Table 135. uniQure Major Business
Table 136. uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 137. uniQure Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 138. uniQure Recent Developments and Future Plans
Table 139. Roche Company Information, Head Office, and Major Competitors
Table 140. Roche Major Business
Table 141. Roche Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 142. Roche Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 143. Roche Recent Developments and Future Plans
Table 144. PTC Therapeutics Company Information, Head Office, and Major Competitors
Table 145. PTC Therapeutics Major Business
Table 146. PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 147. PTC Therapeutics Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 148. PTC Therapeutics Recent Developments and Future Plans
Table 149. BioMarin Company Information, Head Office, and Major Competitors
Table 150. BioMarin Major Business
Table 151. BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 152. BioMarin Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 153. BioMarin Recent Developments and Future Plans
Table 154. CSL Company Information, Head Office, and Major Competitors
Table 155. CSL Major Business
Table 156. CSL Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 157. CSL Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 158. CSL Recent Developments and Future Plans
Table 159. Sarepta Company Information, Head Office, and Major Competitors
Table 160. Sarepta Major Business
Table 161. Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 162. Sarepta Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 163. Sarepta Recent Developments and Future Plans
Table 164. AnGes Company Information, Head Office, and Major Competitors
Table 165. AnGes Major Business
Table 166. AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 167. AnGes Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 168. AnGes Recent Developments and Future Plans
Table 169. bluebird bio Company Information, Head Office, and Major Competitors
Table 170. bluebird bio Major Business
Table 171. bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 172. bluebird bio Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 173. bluebird bio Recent Developments and Future Plans
Table 174. Krystal Biotech Company Information, Head Office, and Major Competitors
Table 175. Krystal Biotech Major Business
Table 176. Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Product and Solutions
Table 177. Krystal Biotech Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 178. Krystal Biotech Recent Developments and Future Plans
Table 179. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue (USD Million) by Players (2020-2025)
Table 180. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Share by Players (2020-2025)
Table 181. Breakdown of Cell and Gene Therapy (CGT) Pharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3)
Table 182. Market Position of Players in Cell and Gene Therapy (CGT) Pharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 183. Head Office of Key Cell and Gene Therapy (CGT) Pharmaceuticals Players
Table 184. Cell and Gene Therapy (CGT) Pharmaceuticals Market: Company Product Type Footprint
Table 185. Cell and Gene Therapy (CGT) Pharmaceuticals Market: Company Product Application Footprint
Table 186. Cell and Gene Therapy (CGT) Pharmaceuticals New Market Entrants and Barriers to Market Entry
Table 187. Cell and Gene Therapy (CGT) Pharmaceuticals Mergers, Acquisition, Agreements, and Collaborations
Table 188. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (USD Million) by Type (2020-2025)
Table 189. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Share by Type (2020-2025)
Table 190. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Forecast by Type (2026-2031)
Table 191. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2025)
Table 192. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Forecast by Application (2026-2031)
Table 193. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2025) & (USD Million)
Table 194. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2026-2031) & (USD Million)
Table 195. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2025) & (USD Million)
Table 196. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2026-2031) & (USD Million)
Table 197. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2025) & (USD Million)
Table 198. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2026-2031) & (USD Million)
Table 199. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2025) & (USD Million)
Table 200. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2026-2031) & (USD Million)
Table 201. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2025) & (USD Million)
Table 202. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2026-2031) & (USD Million)
Table 203. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2025) & (USD Million)
Table 204. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2026-2031) & (USD Million)
Table 205. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2025) & (USD Million)
Table 206. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2026-2031) & (USD Million)
Table 207. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2025) & (USD Million)
Table 208. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2026-2031) & (USD Million)
Table 209. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Region (2020-2025) & (USD Million)
Table 210. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Region (2026-2031) & (USD Million)
Table 211. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2025) & (USD Million)
Table 212. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2026-2031) & (USD Million)
Table 213. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2025) & (USD Million)
Table 214. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2026-2031) & (USD Million)
Table 215. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2025) & (USD Million)
Table 216. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2026-2031) & (USD Million)
Table 217. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2020-2025) & (USD Million)
Table 218. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type (2026-2031) & (USD Million)
Table 219. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2020-2025) & (USD Million)
Table 220. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application (2026-2031) & (USD Million)
Table 221. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2020-2025) & (USD Million)
Table 222. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Country (2026-2031) & (USD Million)
Table 223. Global Key Players of Cell and Gene Therapy (CGT) Pharmaceuticals Upstream (Raw Materials)
Table 224. Global Cell and Gene Therapy (CGT) Pharmaceuticals Typical Customers
LIST OF FIGURES
Figure 1. Cell and Gene Therapy (CGT) Pharmaceuticals Picture
Figure 2. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type in 2024
Figure 4. Cell Therapy Drugs
Figure 5. Gene Therapy Drugs
Figure 6. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application in 2024
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Other Picture
Figure 11. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Market Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 14. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Region (2020-2031)
Figure 15. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Region in 2024
Figure 16. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 17. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 18. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 19. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 20. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Share by Players in 2024
Figure 23. Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 24. Market Share of Cell and Gene Therapy (CGT) Pharmaceuticals by Player Revenue in 2024
Figure 25. Top 3 Cell and Gene Therapy (CGT) Pharmaceuticals Players Market Share in 2024
Figure 26. Top 6 Cell and Gene Therapy (CGT) Pharmaceuticals Players Market Share in 2024
Figure 27. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Share by Type (2020-2025)
Figure 28. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share Forecast by Type (2026-2031)
Figure 29. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Share by Application (2020-2025)
Figure 30. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share Forecast by Application (2026-2031)
Figure 31. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type (2020-2031)
Figure 32. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application (2020-2031)
Figure 33. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Country (2020-2031)
Figure 34. United States Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 35. Canada Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 36. Mexico Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 37. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type (2020-2031)
Figure 38. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application (2020-2031)
Figure 39. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Country (2020-2031)
Figure 40. Germany Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 41. France Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 42. United Kingdom Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 43. Russia Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 44. Italy Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 45. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type (2020-2031)
Figure 46. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application (2020-2031)
Figure 47. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Region (2020-2031)
Figure 48. China Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 49. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 50. South Korea Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 51. India Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 52. Southeast Asia Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 53. Australia Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 54. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type (2020-2031)
Figure 55. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application (2020-2031)
Figure 56. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Country (2020-2031)
Figure 57. Brazil Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 58. Argentina Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 59. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type (2020-2031)
Figure 60. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application (2020-2031)
Figure 61. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Country (2020-2031)
Figure 62. Turkey Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 63. Saudi Arabia Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 64. UAE Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 65. Cell and Gene Therapy (CGT) Pharmaceuticals Market Drivers
Figure 66. Cell and Gene Therapy (CGT) Pharmaceuticals Market Restraints
Figure 67. Cell and Gene Therapy (CGT) Pharmaceuticals Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Cell and Gene Therapy (CGT) Pharmaceuticals Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Cell and Gene Therapy (CGT) Pharmaceuticals Picture
Figure 2. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type in 2024
Figure 4. Cell Therapy Drugs
Figure 5. Gene Therapy Drugs
Figure 6. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application in 2024
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Other Picture
Figure 11. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Market Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 14. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Region (2020-2031)
Figure 15. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Region in 2024
Figure 16. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 17. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 18. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 19. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 20. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Cell and Gene Therapy (CGT) Pharmaceuticals Revenue Share by Players in 2024
Figure 23. Cell and Gene Therapy (CGT) Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 24. Market Share of Cell and Gene Therapy (CGT) Pharmaceuticals by Player Revenue in 2024
Figure 25. Top 3 Cell and Gene Therapy (CGT) Pharmaceuticals Players Market Share in 2024
Figure 26. Top 6 Cell and Gene Therapy (CGT) Pharmaceuticals Players Market Share in 2024
Figure 27. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Share by Type (2020-2025)
Figure 28. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share Forecast by Type (2026-2031)
Figure 29. Global Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Share by Application (2020-2025)
Figure 30. Global Cell and Gene Therapy (CGT) Pharmaceuticals Market Share Forecast by Application (2026-2031)
Figure 31. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type (2020-2031)
Figure 32. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application (2020-2031)
Figure 33. North America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Country (2020-2031)
Figure 34. United States Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 35. Canada Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 36. Mexico Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 37. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type (2020-2031)
Figure 38. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application (2020-2031)
Figure 39. Europe Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Country (2020-2031)
Figure 40. Germany Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 41. France Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 42. United Kingdom Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 43. Russia Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 44. Italy Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 45. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type (2020-2031)
Figure 46. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application (2020-2031)
Figure 47. Asia-Pacific Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Region (2020-2031)
Figure 48. China Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 49. Japan Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 50. South Korea Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 51. India Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 52. Southeast Asia Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 53. Australia Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 54. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type (2020-2031)
Figure 55. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application (2020-2031)
Figure 56. South America Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Country (2020-2031)
Figure 57. Brazil Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 58. Argentina Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 59. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Type (2020-2031)
Figure 60. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Application (2020-2031)
Figure 61. Middle East & Africa Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value Market Share by Country (2020-2031)
Figure 62. Turkey Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 63. Saudi Arabia Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 64. UAE Cell and Gene Therapy (CGT) Pharmaceuticals Consumption Value (2020-2031) & (USD Million)
Figure 65. Cell and Gene Therapy (CGT) Pharmaceuticals Market Drivers
Figure 66. Cell and Gene Therapy (CGT) Pharmaceuticals Market Restraints
Figure 67. Cell and Gene Therapy (CGT) Pharmaceuticals Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Cell and Gene Therapy (CGT) Pharmaceuticals Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
